This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n10http://linked.opendata.cz/resource/drugbank/drug/DB04708/identifier/pdb/
n7http://linked.opendata.cz/resource/drugbank/drug/DB04708/identifier/pubchem-compound/
n13http://bio2rdf.org/drugbank:
n8http://linked.opendata.cz/resource/drugbank/drug/DB04708/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB04708/identifier/drugbank/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB04708
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n12:DB04708 n13:DB04708
dcterms:title
(S)-TETRAHYDROFURAN-3-YL (2S,3S)-4-((S)-4-((1R,3R)-3-(2-AMINO-2-OXOETHYL)-2,3-DIHYDRO-1H-INDEN-1-YL)-2-BENZYL-3-OXO-2,3-DIHYDRO-1H-PYRROL-2-YL)-3-HYDROXY-1-PHENYLBUTAN-2-YLCARBAMATE
adms:identifier
n7:5459370 n8:46508773 n9:DB04708 n10:HH1
n3:IUPAC-Name
n4:271B4BCA-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B4BD0-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B4BCF-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B4BCC-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B4BCD-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B4BCE-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B4BC8-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B4BC9-363D-11E5-9242-09173F13E4C5 n4:271B4BC6-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B4BC7-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B4BD6-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B4BD7-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B4BD1-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B4BD2-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B4BD4-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B4BD3-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B4BD5-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B4BDC-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B4BDE-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B4BDF-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B4BDB-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B4BDA-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B4BDD-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B4BCB-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B4BD8-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B4BD9-363D-11E5-9242-09173F13E4C5